186 related articles for article (PubMed ID: 19527605)
1. The efficiency of Percoll and Ficoll density gradient media in the isolation of marrow derived human mesenchymal stem cells with osteogenic potential.
Chang Y; Hsieh PH; Chao CC
Chang Gung Med J; 2009; 32(3):264-75. PubMed ID: 19527605
[TBL] [Abstract][Full Text] [Related]
2. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow.
D'Ippolito G; Schiller PC; Ricordi C; Roos BA; Howard GA
J Bone Miner Res; 1999 Jul; 14(7):1115-22. PubMed ID: 10404011
[TBL] [Abstract][Full Text] [Related]
3. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
[TBL] [Abstract][Full Text] [Related]
4. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis.
Stenderup K; Justesen J; Eriksen EF; Rattan SI; Kassem M
J Bone Miner Res; 2001 Jun; 16(6):1120-9. PubMed ID: 11393789
[TBL] [Abstract][Full Text] [Related]
5. CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque.
Georgiou GM; Roberton DM; Ellis WM; Shen BJ; Ekert H; Hosking CS
Clin Exp Immunol; 1983 Aug; 53(2):491-6. PubMed ID: 6309446
[TBL] [Abstract][Full Text] [Related]
6. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study.
Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O
Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078
[TBL] [Abstract][Full Text] [Related]
7. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions.
Seebach C; Henrich D; Tewksbury R; Wilhelm K; Marzi I
Calcif Tissue Int; 2007 Apr; 80(4):294-300. PubMed ID: 17431529
[TBL] [Abstract][Full Text] [Related]
8. Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols.
Bourzac C; Smith LC; Vincent P; Beauchamp G; Lavoie JP; Laverty S
Equine Vet J; 2010 Sep; 42(6):519-27. PubMed ID: 20716192
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets.
Dvorakova J; Hruba A; Velebny V; Kubala L
Cell Biol Int; 2008 Sep; 32(9):1116-25. PubMed ID: 18562221
[TBL] [Abstract][Full Text] [Related]
10. A non-contact suspension culture approach to the culture of osteogenic cells derived from a CD49elow subpopulation of human bone marrow-derived cells.
Baksh D; Zandstra PW; Davies JE
Biotechnol Bioeng; 2007 Dec; 98(6):1195-208. PubMed ID: 17614333
[TBL] [Abstract][Full Text] [Related]
11. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis.
Horn P; Bork S; Diehlmann A; Walenda T; Eckstein V; Ho AD; Wagner W
Cytotherapy; 2008; 10(7):676-85. PubMed ID: 18985474
[TBL] [Abstract][Full Text] [Related]
12. Effect of donor characteristics, technique of harvesting and in vitro processing on culturing of human marrow stroma cells for tissue engineered growth of bone.
Bertram H; Mayer H; Schliephake H
Clin Oral Implants Res; 2005 Oct; 16(5):524-31. PubMed ID: 16164457
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy.
Gentry T; Foster S; Winstead L; Deibert E; Fiordalisi M; Balber A
Cytotherapy; 2007; 9(3):259-74. PubMed ID: 17464758
[TBL] [Abstract][Full Text] [Related]
14. IMT504, the prototype of the immunostimulatory oligonucleotides of the PyNTTTTGT class, increases the number of progenitors of mesenchymal stem cells both in vitro and in vivo: potential use in tissue repair therapy.
Hernando Insúa A; Montaner AD; Rodriguez JM; Elías F; Fló J; López RA; Zorzopulos J; Hofer EL; Chasseing NA
Stem Cells; 2007 Apr; 25(4):1047-54. PubMed ID: 17420228
[TBL] [Abstract][Full Text] [Related]
15. Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction.
Mueller LP; Luetzkendorf J; Mueller T; Reichelt K; Simon H; Schmoll HJ
Stem Cells; 2006 Dec; 24(12):2753-65. PubMed ID: 16931776
[TBL] [Abstract][Full Text] [Related]
16. In vivo comparison of hard tissue regeneration with human mesenchymal stem cells processed with either the FICOLL method or the BMAC method.
Sauerbier S; Stricker A; Kuschnierz J; Bühler F; Oshima T; Xavier SP; Schmelzeisen R; Gutwald R
Tissue Eng Part C Methods; 2010 Apr; 16(2):215-23. PubMed ID: 19473102
[TBL] [Abstract][Full Text] [Related]
17. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule.
Gindraux F; Selmani Z; Obert L; Davani S; Tiberghien P; Hervé P; Deschaseaux F
Cell Tissue Res; 2007 Mar; 327(3):471-83. PubMed ID: 17109120
[TBL] [Abstract][Full Text] [Related]
18. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering.
Siddappa R; Licht R; van Blitterswijk C; de Boer J
J Orthop Res; 2007 Aug; 25(8):1029-41. PubMed ID: 17469183
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of mouse mesenchymal stem cells.
Sung JH; Yang HM; Park JB; Choi GS; Joh JW; Kwon CH; Chun JM; Lee SK; Kim SJ
Transplant Proc; 2008 Oct; 40(8):2649-54. PubMed ID: 18929828
[TBL] [Abstract][Full Text] [Related]
20. Standardized isolation of human mesenchymal stromal cells with red blood cell lysis.
Horn P; Bork S; Wagner W
Methods Mol Biol; 2011; 698():23-35. PubMed ID: 21431508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
